arrow
D

David H. Lum

Huntsman Cancer Institute
H指数:20
被引数:3,638

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function

通过抑制组织蛋白酶B防止吞噬作用增强了CAR T细胞功能

2026-04-220
OAAI
Identification and characterization of BRAF⇔TP53 interactions in melanoma

BRAF⇔TP53相互作用在黑色素瘤中的鉴定与表征

2026-03-200
OAAI
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers (vol 25, pg 620, 2019)

RAF→MEK→ERK抑制所诱发的保护性自噬表明了一种针对RAS驱动型癌症的治疗策略(卷25,页620,2019)

2025-04-250
PRE
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment
2024-12-030
OAAI
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
2023-09-273
OAAI
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

用于药物发现和精确肿瘤学的人类乳腺癌衍生异种移植物和类器官平台

2022-02-24184
OAAI
Protective autophagy elicited by RAF®MEK®ERK inhibition suggests a treatment strategy for pancreatic cancer
2019-07-010
PRE
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers (vol 25, pg 620, 2019)
2019-03-2719
OAAI
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers

Raf → mek → erk抑制引起的保护性自噬提示RAS驱动的癌症的治疗策略

2019-03-04500
OAAI